Abstract: An oral dosage form comprising an erodable core, which core comprises Compound A or a pharmaceutically acceptable salt or solvate thereof and another antidiabetic agent, the core having a coating with one or more openings, characterised in that the coating is erodable under predetermined pH conditions; a process for preparing such a dosage form and the use of such a dosage form in medicine.
Type:
Application
Filed:
August 9, 2004
Publication date:
August 28, 2008
Applicant:
SB PHARMCO PURERTO RICO INC. The Prentice Hall Corp. System of P.R. Inc.
Inventors:
Peter John Coles, Donald Colin Mackenzie, Paul Norman Mudd